These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18427896)

  • 1. Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?
    Al Lawati NM; Ayas NT
    Lung; 2008; 186(4):195-196. PubMed ID: 18427896
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension.
    Zamarrón C; Ricoy J; Riveiro A; Gude F
    Lung; 2008; 186(3):151-156. PubMed ID: 18330639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Plasminogen System and Transforming Growth Factor-β in Subjects With Obstructive Sleep Apnea Syndrome: Effects of CPAP Treatment.
    Steffanina A; Proietti L; Antonaglia C; Palange P; Angelici E; Canipari R
    Respir Care; 2015 Nov; 60(11):1643-51. PubMed ID: 26286733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen, stroke, and obstructive sleep apnea: an evolving paradigm of cardiovascular risk.
    Shamsuzzaman AS; Somers VK
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2018-20. PubMed ID: 11112100
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of cardiovascular risk factors by obstructive sleep apnea.
    Olson LJ; Somers VK
    Chest; 2006 Feb; 129(2):218-220. PubMed ID: 16478831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beneficial effect of continuous positive airway pressure therapy in obstructive sleep apnea syndrome].
    Magyar MT
    Orv Hetil; 2014 Nov; 155(47):1855-9. PubMed ID: 25403278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the systemic complications of obstructive sleep apnea in the development of cardiovascular pathology].
    Romanov AI; Kallistov DIu
    Fiziol Zh (1994); 2011; 57(5):70-2. PubMed ID: 22276312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular biomarkers in clinical practice of sleep apnea].
    Dursunoğlu D; Dursunoğlu N
    Tuberk Toraks; 2011; 59(4):402-8. PubMed ID: 22233315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell distribution width and uric acid in patients with obstructive sleep apnea.
    Sunnetcioglu A; Gunbatar H; Yıldız H
    Clin Respir J; 2018 Mar; 12(3):1046-1052. PubMed ID: 28296212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea.
    Zakrzewski M; Zakrzewska E; Kiciński P; Przybylska-Kuć S; Dybała A; Myśliński W; Pastryk J; Tomaszewski T; Mosiewicz J
    PLoS One; 2016; 11(11):e0166725. PubMed ID: 27861608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome.
    Hanikoglu F; Huseyinoglu N; Ozben S; Cort A; Ozdem S; Ozben T
    Int J Neurosci; 2015; 125(9):655-62. PubMed ID: 25180986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome.
    Kokturk O; Ciftci TU; Mollarecep E; Ciftci B
    Int Heart J; 2005 Sep; 46(5):801-9. PubMed ID: 16272771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
    Kanbay A; Ceylan E; Köseoğlu Hİ; Çalışkan M; Takir M; Tulu S; Telci Çaklılı O; Köstek O; Erek A; Afsar B
    Clin Respir J; 2018 Jan; 12(1):84-90. PubMed ID: 27116287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cardiovascular risk factors in obstructive sleep apnea.
    Can M; Açikgöz Ş; Mungan G; Bayraktaroğlu T; Koçak E; Güven B; Demirtas S
    Chest; 2006 Feb; 129(2):233-237. PubMed ID: 16478836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of upper airway surgery and improved cardiovascular biomarkers and risk in OSA.
    Qian Y; Zou J; Xu H; Zhu H; Meng L; Liu S; Yi H; Guan J; Yin S
    Laryngoscope; 2020 Mar; 130(3):818-824. PubMed ID: 31077395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activity and cardiovascular risk in obesity and obstructive sleep apnea: compelling need for interdisciplinary research?
    Peker Y
    J Clin Sleep Med; 2011 Apr; 7(2):179-80. PubMed ID: 21509333
    [No Abstract]   [Full Text] [Related]  

  • 17. Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study.
    Inonu Koseoglu H; Pazarli AC; Kanbay A; Demir O
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):139-144. PubMed ID: 27837155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rheological properties of blood and the risk of cardiovascular disease in patients with obstructive sleep apnea syndrome (OSAS).
    Tażbirek M; Słowińska L; Kawalski M; Pierzchała W
    Folia Histochem Cytobiol; 2011; 49(2):206-10. PubMed ID: 21744318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive sleep apnea and cardiovascular disease.
    Parish JM; Somers VK
    Mayo Clin Proc; 2004 Aug; 79(8):1036-46. PubMed ID: 15301332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome.
    Kokturk O; Ciftci TU; Mollarecep E; Ciftci B
    Respir Med; 2006 Mar; 100(3):536-41. PubMed ID: 16024243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.